Connect Biopharma Holdings Ltd (CNTB)

Mar 12, 2026

Severe Asthma Pipeline 2026: Key Companies, MOA, ROA, and Clinical Trials Evaluation by DelveInsight | Lanier Biotherapeutics, Bio-Thera Solutions, Kinaset Therapeutics, CSPC ZhongQi Pharma - StreetInsider

Mar 12, 2026

Mar 11, 2026

Connect Biopharma Holdings Limited Sponsored ADR (NASDAQ:CNTB) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat

Mar 11, 2026

Mar 10, 2026

Connect Biopharma and Bimergen Energy Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Springfield News-Leader

Mar 10, 2026

Mar 10, 2026

Simcere’s rademikibart AD study selected for AAD presentation - Investing.com

Mar 10, 2026

Mar 10, 2026

Results from Phase 3 Study of Rademikibart in Moderate-to-Severe Atopic Dermatitis to be Presented in the Late-Breaking Research Session at the 2026 American Academy of Dermatology (AAD) Annual Meeting - Bitget

Mar 10, 2026

Mar 10, 2026

Severe eczema drug from Connect Biopharma lands late-breaking AAD slot - Stock Titan

Mar 10, 2026

Mar 04, 2026

COYA Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

Mar 04, 2026

Mar 03, 2026

Connect Biopharma to Present at the Leerink Partners Global Healthcare Conference - The Manila Times

Mar 03, 2026

Mar 03, 2026

CNTB Earning Date, Earning Analysis and Earning Prediction - Intellectia AI

Mar 03, 2026

Mar 01, 2026

GNLX Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI

Mar 01, 2026

Feb 28, 2026

SELX Stock News Today | Earnings, Events & Price Alerts - Intellectia AI

Feb 28, 2026

Feb 28, 2026

CNTB Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

Feb 28, 2026

Feb 28, 2026

UCL Stock News Today | Earnings, Events & Price Alerts - Intellectia AI

Feb 28, 2026

Feb 27, 2026

CNTB Technical Analysis & Stock Price Forecast - Intellectia AI

Feb 27, 2026

Feb 27, 2026

Connect Biopharma Touts Rademikibart as Fast-Acting Option for Acute Asthma, COPD Flare-Ups at Conference - MarketBeat

Feb 27, 2026

Feb 23, 2026

BML Capital Management LLC Sells 554,058 Shares of Connect Biopharma Holdings Limited Sponsored ADR $CNTB - MarketBeat

Feb 23, 2026

Feb 23, 2026

KraneShares CSI China Internet ETF $KWEB Shares Purchased by Aurora Investment Managers LLC. - Defense World

Feb 23, 2026

Feb 23, 2026

Invesco QQQ $QQQ Stock Position Lessened by Concentrum Wealth Management - Defense World

Feb 23, 2026

Feb 23, 2026

JD.com, Inc. $JD Shares Acquired by Aurora Investment Managers LLC. - Defense World

Feb 23, 2026

Feb 23, 2026

BML Capital Management LLC Makes New Investment in ImageneBio, Inc. $IMA - Defense World

Feb 23, 2026

Feb 19, 2026

Connect Biopharma to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference - The Manila Times

Feb 19, 2026

Feb 19, 2026

Watch Connect Biopharma's Oppenheimer health conference talk online - Stock Titan

Feb 19, 2026

Feb 17, 2026

Wubin Pan and BioFortune Inc. disclose 10.8% stake in Connect Biopharma (CNTB) - Stock Titan

Feb 17, 2026

Feb 16, 2026

Atopic Dermatitis Market to Accelerate at a Rapid Pace by 2034 with Advancements in Biologics and JAK Inhibitors | DelveInsight - Financial Times

Feb 16, 2026

Feb 14, 2026

Connect Biopharma Holdings Limited Sponsored ADR (NASDAQ:CNTB) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat

Feb 14, 2026

Feb 13, 2026

CNTB PE Ratio & Valuation, Is CNTB Overvalued - Intellectia AI

Feb 13, 2026

Jan 28, 2026

What is HC Wainwright's Forecast for CNTB FY2028 Earnings? - MarketBeat

Jan 28, 2026

Jan 27, 2026

Equities Analysts Offer Predictions for CNTB FY2030 Earnings - MarketBeat

Jan 27, 2026

Jan 23, 2026

Analysts Offer Insights on Healthcare Companies: Rani Therapeutics Holdings (RANI), Ardelyx (ARDX) and AxoGen (AXGN) - The Globe and Mail

Jan 23, 2026

Jan 22, 2026

Analysts’ Top Healthcare Picks: Context Therapeutics (CNTX), Connect Biopharma Holdings (CNTB) - The Globe and Mail

Jan 22, 2026

Jan 21, 2026

3 Promising Penny Stocks With Market Caps Up To $400M - Yahoo Finance

Jan 21, 2026

Jan 20, 2026

Connect Biopharma Holdings Limited Sponsored ADR (NASDAQ:CNTB) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat

Jan 20, 2026

Jan 20, 2026

OPAL Fuels Inc. (NASDAQ:OPAL) Given Average Recommendation of “Reduce” by Analysts - Defense World

Jan 20, 2026

Jan 20, 2026

NVR, Inc. (NYSE:NVR) Receives Average Rating of “Moderate Buy” from Analysts - Defense World

Jan 20, 2026

Jan 20, 2026

Contrasting Joint Stock Company Kaspi.kz (NASDAQ:KSPI) & PagSeguro Digital (NYSE:PAGS) - Defense World

Jan 20, 2026

Jan 17, 2026

Connect Biopharma (NASDAQ:CNTB) Shares Down 2.7%What's Next? - MarketBeat

Jan 17, 2026

Jan 17, 2026

Connect Biopharma (NASDAQ:CNTB) Shares Down 2.7% – What’s Next? - Defense World

Jan 17, 2026

Jan 14, 2026

Plus Therapeutics Spurs After-Hours Biotech Rally; Connect Biopharma And Elutia Also Advance - Nasdaq

Jan 14, 2026

Jan 12, 2026

Connect Biopharma Highlights New Mechanism of Action Data for Rademikibart and Outlines Priorities for 2026 - The Manila Times

Jan 12, 2026

Jan 10, 2026

Connect Biopharma Reports Significant Loss Amid Development Efforts - MSN

Jan 10, 2026

Jan 07, 2026

Join Connect Biopharma's Exclusive Live Investor Webinar and Q&A Session on November 3 - news-journalonline.com

Jan 07, 2026

Jan 05, 2026

12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga

Jan 05, 2026

Dec 31, 2025

Aptevo Therapeutics (APVO) Stock Price, Quote, News & History - Benzinga

Dec 31, 2025

Dec 26, 2025

Connect Biopharma Holdings Limited Sponsored ADR (NASDAQ:CNTB) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat

Dec 26, 2025

Dec 23, 2025

Connect Biopharma Announces Board Resignation - TradingView — Track All Markets

Dec 23, 2025

Dec 23, 2025

Discovering Connect Biopharma Holdings And 2 Other Promising Penny Stocks - simplywall.st

Dec 23, 2025